Bruce Jackson
Stock Analyst at Benchmark
(1.03)
# 3,852
Out of 5,044 analysts
123
Total ratings
29.46%
Success rate
-18.87%
Average return
Main Sectors:
Stocks Rated by Bruce Jackson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ABT Abbott Laboratories | Initiates: Buy | $145 | $126.61 | +14.52% | 1 | Oct 10, 2025 | |
| CV CapsoVision | Initiates: Speculative Buy | $5 | $4.69 | +6.61% | 1 | Jul 28, 2025 | |
| BFRI Biofrontera | Maintains: Buy | $7 → $2.75 | $1.06 | +159.43% | 8 | May 19, 2025 | |
| HUMA Humacyte | Maintains: Buy | $17 → $14 | $1.70 | +723.53% | 15 | May 14, 2025 | |
| HBIO Harvard Bioscience | Maintains: Speculative Buy | $4.5 → $3 | $0.40 | +650.19% | 6 | May 13, 2025 | |
| CLNN Clene | Maintains: Buy | $84 → $33 | $9.37 | +252.19% | 8 | May 8, 2025 | |
| GNLX Genelux | Maintains: Speculative Buy | $25 → $23 | $7.64 | +201.05% | 7 | May 8, 2025 | |
| BLTE Belite Bio | Reiterates: Buy | $80 | $93.24 | -14.20% | 9 | Mar 26, 2025 | |
| NEO NeoGenomics | Reiterates: Hold | n/a | $9.92 | - | 8 | Jan 16, 2025 | |
| EXAS Exact Sciences | Reiterates: Buy | $65 | $63.30 | +2.69% | 7 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $0.42 | - | 3 | Nov 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $30 | $4.72 | +535.59% | 8 | Nov 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $1.25 | $0.46 | +172.87% | 2 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $3 | $1.39 | +115.83% | 3 | Oct 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $5 | $2.39 | +109.21% | 4 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $300 | $6.76 | +4,337.87% | 2 | Sep 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $60 | $4.24 | +1,315.09% | 5 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $17 | $0.58 | +2,844.74% | 4 | Aug 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $24 | $1.22 | +1,867.21% | 3 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $5 | $0.54 | +827.30% | 4 | Mar 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $1.46 | - | 7 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $27.16 | - | 7 | Sep 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Speculative Buy | $800 | $3.16 | +25,216.46% | 1 | Aug 8, 2022 |
Abbott Laboratories
Oct 10, 2025
Initiates: Buy
Price Target: $145
Current: $126.61
Upside: +14.52%
CapsoVision
Jul 28, 2025
Initiates: Speculative Buy
Price Target: $5
Current: $4.69
Upside: +6.61%
Biofrontera
May 19, 2025
Maintains: Buy
Price Target: $7 → $2.75
Current: $1.06
Upside: +159.43%
Humacyte
May 14, 2025
Maintains: Buy
Price Target: $17 → $14
Current: $1.70
Upside: +723.53%
Harvard Bioscience
May 13, 2025
Maintains: Speculative Buy
Price Target: $4.5 → $3
Current: $0.40
Upside: +650.19%
Clene
May 8, 2025
Maintains: Buy
Price Target: $84 → $33
Current: $9.37
Upside: +252.19%
Genelux
May 8, 2025
Maintains: Speculative Buy
Price Target: $25 → $23
Current: $7.64
Upside: +201.05%
Belite Bio
Mar 26, 2025
Reiterates: Buy
Price Target: $80
Current: $93.24
Upside: -14.20%
NeoGenomics
Jan 16, 2025
Reiterates: Hold
Price Target: n/a
Current: $9.92
Upside: -
Exact Sciences
Jan 13, 2025
Reiterates: Buy
Price Target: $65
Current: $63.30
Upside: +2.69%
Nov 22, 2024
Reiterates: Hold
Price Target: n/a
Current: $0.42
Upside: -
Nov 22, 2024
Reiterates: Speculative Buy
Price Target: $30
Current: $4.72
Upside: +535.59%
Nov 20, 2024
Reiterates: Speculative Buy
Price Target: $1.25
Current: $0.46
Upside: +172.87%
Oct 11, 2024
Reiterates: Speculative Buy
Price Target: $3
Current: $1.39
Upside: +115.83%
Oct 10, 2024
Reiterates: Speculative Buy
Price Target: $5
Current: $2.39
Upside: +109.21%
Sep 4, 2024
Reiterates: Speculative Buy
Price Target: $300
Current: $6.76
Upside: +4,337.87%
Aug 27, 2024
Reiterates: Speculative Buy
Price Target: $60
Current: $4.24
Upside: +1,315.09%
Aug 26, 2024
Reiterates: Speculative Buy
Price Target: $17
Current: $0.58
Upside: +2,844.74%
Aug 14, 2024
Reiterates: Speculative Buy
Price Target: $24
Current: $1.22
Upside: +1,867.21%
Mar 21, 2024
Reiterates: Speculative Buy
Price Target: $5
Current: $0.54
Upside: +827.30%
Nov 14, 2023
Downgrades: Hold
Price Target: n/a
Current: $1.46
Upside: -
Sep 15, 2023
Downgrades: Hold
Price Target: n/a
Current: $27.16
Upside: -
Aug 8, 2022
Initiates: Speculative Buy
Price Target: $800
Current: $3.16
Upside: +25,216.46%